CompoAtlas

Recharge

Food supplement declared in France, declaration No 2022-2-381, decision dated 7 February 2022

Recharge (Femarelle) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 2 rules of use apply to its ingredients (limits and warnings).

Brand
Femarelle
Food business operator placing the product on the market
THERAMEX FRANCE
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2 gélules par jour
Directions for use
1 gélule, deux fois par jour (matin et soir); pendant ou en dehors des repas
Intended populations
Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Antécédent de cancer du sein, Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Ménopause

Declaration 324844, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Glycine max. (L.) Merr.GraineAutre extrait sec644 mg
Linum usitatissimum L.GraineAutre extrait sec216 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Chlorhydrate de pyridoxineVitamine B612 mg2 mg

Other ingredients

gélatine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2022. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

Ne convient pas aux femmes enceintes et à celles qui allaitent. Ne convient pas aux femmes qui ont des antécédents personnels ou familiaux de cancer du sein.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Femarelle

List recorded in 2022. Photograph the packaging to check whether it has changed.